Cargando…

Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer

BACKGROUND: Salvage endoscopic therapy (SET), such as endoscopic mucosal resection (EMR) and photodynamic therapy (PDT), is a less-invasive treatment for local failure at the primary site after chemoradiotherapy (CRT) for esophageal squamous cell carcinoma (ESCC). We conducted this retrospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatogai, Ken, Yano, Tomonori, Kojima, Takashi, Onozawa, Masakatsu, Fujii, Satoshi, Daiko, Hiroyuki, Yoda, Yusuke, Hombu, Takuya, Doi, Toshihiko, Kaneko, Kazuhiro, Ohtsu, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769588/ https://www.ncbi.nlm.nih.gov/pubmed/26922374 http://dx.doi.org/10.1186/s13014-016-0604-z

Ejemplares similares

Feasibility of salvage endoscopic resection for patients with locoregional failure after definitive radiotherapy for pharyngeal cancer
por: Satake, Hironaga, et al.
Publicado: (2015)

Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma
por: Hatogai, Ken, et al.
Publicado: (2017)

Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma
por: Hatogai, Ken, et al.
Publicado: (2019)

Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients
por: Kadota, Tomohiro, et al.
Publicado: (2018)

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma
por: Hatogai, Ken, et al.
Publicado: (2016)

Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report
por: Hirose, Wataru, et al.
Publicado: (2021)

Salvage esophagectomy with pancreatectomy for local recurrence of thoracic esophageal cancer after definitive chemoradiotherapy: A case report
por: Nishiwaki, Noriyuki, et al.
Publicado: (2017)

Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer
por: Yano, Tomonori, et al.
Publicado: (2012)

Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma
por: Ito, Renma, et al.
Publicado: (2022)

Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma
por: Morimoto, Hiroyuki, et al.
Publicado: (2017)

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2014)

Salvage Robotic-Assisted Thoracoscopic Esophagectomy after Definitive Chemoradiotherapy for Clinical T4b Esophageal Cancer: A Case Report
por: Sasamori, Ryohei, et al.
Publicado: (2021)

Salvage Resection for Isolated Local and/or Regional Failure of Head/Neck Cancer Following Definitive Concurrent Chemoradiotherapy Case Series and Review of the Literature.
por: Kearney, Patricia L., et al.
Publicado: (2011)

Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?
por: Yu, Hsuan-Hsuan, et al.
Publicado: (2021)

Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
por: Yagi, Koichi, et al.
Publicado: (2021)

Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC
por: Joosten, Pieter J.M., et al.
Publicado: (2021)

Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies
por: Doi, Toshihiko, et al.
Publicado: (2020)

Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study
por: Kawai, Sadayuki, et al.
Publicado: (2017)

Salvage esophagectomy under bilateral thoracotomy after definitive chemoradiotherapy for aorta T4 thoracic esophageal squamous cell carcinoma: Report of a case
por: Nagaki, Yushi, et al.
Publicado: (2015)

Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)
por: Tahara, Makoto, et al.
Publicado: (2015)

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer
por: Hamada, Akira, et al.
Publicado: (2021)

Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP
por: Faehling, Martin, et al.
Publicado: (2020)

FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy
por: Iwabu, Jun, et al.
Publicado: (2019)

An extended modification of transmanubrial osteomuscular sparing approach: salvage resection for recurrent superior sulcus lung cancer after definitive chemoradiotherapy
por: Sakakura, Noriaki, et al.
Publicado: (2021)

Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus
por: Kaneko, K, et al.
Publicado: (2003)

Prophylactic steroid administration for strictures after endoscopic resection of large superficial esophageal squamous cell carcinoma
por: Kadota, Tomohiro, et al.
Publicado: (2016)

Salvage high intensity focused ultrasound for residual or recurrent cervical cancer after definitive chemoradiotherapy
por: Zhong, Qin, et al.
Publicado: (2022)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2014)

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by radical surgery for locally advanced oesophageal squamous cell carcinoma: meta-analysis
por: Kamarajah, Sivesh K, et al.
Publicado: (2022)

Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
por: Schreiner, Waldemar, et al.
Publicado: (2016)

A case of Barrett’s esophageal adenocarcinoma and severe scoliosis with successful salvage esophagectomy after definitive chemoradiotherapy
por: Taguchi, Daisuke, et al.
Publicado: (2023)

Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis
por: Mayahara, Hiroshi, et al.
Publicado: (2012)

Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older
por: Nishikawa, Michiko, et al.
Publicado: (2022)

Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy
por: Kim, Dae-Eun, et al.
Publicado: (2013)

Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
por: Xu, Yun, et al.
Publicado: (2016)

Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
por: Chen, Chih-Yi, et al.
Publicado: (2018)

Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
por: Ochi, Masanori, et al.
Publicado: (2020)

Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Sapienza, Lucas G, et al.
Publicado: (2022)

Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma
por: Doi, Hiroshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v5973drjk97kd9nc1s6d4pi13p